Board of Directors

The Board approves strategic directions, organisation structure, policies and implementation processes. Directors observe corporate governance principles and a code of conduct in keeping with the Corporations Act and the Australian Charities and Not-for-profits Commission governance standards.

All other Board committees support and report to the Board. It meets regularly and reports to the Members of the Company on whose behalf it makes decisions. The CEO is appointed by and reports to the Board.

(See our glossary of medical and professional acronyms for details of qualifications).

 Board Members

Maria Trinci Ms Maria Trinci
Chair of Board
BComm, BA, CA

A Partner at KPMG specialising in providing audit and advisory services to the financial services sector. Maria has over 15 years’ experience in auditing and extensive project management experience. She provides accounting advice in the area of deal structuring, funding and hedging to a number of industries. She was initially appointed as a Cancer Council Victoria Executive Committee member and as a member of the Finance, Risk & Audit Committee in 2010. Since 1 October 2015 Maria has acted in the nonexecutive roles of Deputy Chair of the Board of Directors of the Company and Chair of the Company’s Finance, Risk & Audit Committee.

Professor Joe Trapani Professor Joe Trapani
Chair Medical & Scientific Committee

Executive Director Cancer Research and Head of the Cancer Immunology Program at the Peter Board of Directors MacCallum Cancer Centre in Melbourne. He is Head of the Sir Peter MacCallum Department of Oncology at The University of Melbourne and has an adjunct professorial appointment in the Department of Biochemistry and Molecular Biology at Monash University. Joe was a Senior Principal Research Fellow of the National Health and Medical Research Council (2003-10) and leads an NHMRC Program grant in Cancer Immunotherapy (2003-2022). Appointed by the Medical and Scientific Committee as an Executive Committee member in 2007, since 1 October 2015 he has continued in the role of Director and Chair of the Medical and Scientific Committee.

Mr David Gibbs Mr David Gibbs
BCom (Melb), FCA, FAICD, TEP

A business strategist and adviser, David has over 35 years' experience in business, sharpening his passion for Corporate Governance and the identification and management of risk. He’s a committed supporter for a number of community-based and youth organisations, including a foundation director of the Melbourne Community Foundation. David also served as the Chairman of the Victorian State Council of Chartered Accountants Australia & New Zealand. Joining the Cancer Council Executive Committee in 2008, David continues in the role of Director and has been a member of the Company’s Finance, Risk & Audit Committee since 1 October 2015.

Associate Professor Jeremy Millar Professor Jeremy Millar
Deputy Chair

Director of Radiation Oncology at Alfred Health in Melbourne, responsible for an academic radiation treatment centre in metropolitan Melbourne, as well as Alfred Health’s satellite regional radiation treatment centre in Gippsland. He is a non-Executive Director of Cancer Council Australia and a Professor at Monash University working in cancer clinical quality registries, particularly in prostate cancer. Jeremy is the Chair of Cancer Council Victoria’s Clinical Network and a past Chair of the VCOG Urological Cancer Committee. He has also served as Director of the Southern Melbourne Integrated Cancer Service. He was initially appointed as a Cancer Council Victoria Executive Committee member in 2013 and since 1 October 2015 has continued to act in the role of Director on the Board of Directors.

Dr Mukesh Haikerwal AO Dr Mukesh Haikerwal AC

A General Medical Practitioner in Melbourne’s Western Suburbs where he has practised since 1990. He has held high offices in Victoria, nationally and internationally including a Professorial Fellow at Flinders University, on the Board of beyondblue, an AMA Gold Medalist, a Life Fellow of the Royal Australian College of General Practitioners and Commissioner of the National Health & Hospitals Reform Commission. Past roles include chair of the Australian Institute of Health and Welfare, the 19th Federal President of the AMA, its Federal Vice President, and prior to that AMA Victoria State President. Mukesh has been a Director since 2015.

Mr Andrew Dyer

A company director who serves on a number of boards in the government, commercial and not-for-profit sectors. He is also a Professorial Fellow at Monash University and the National Wind Farm Commissioner. Andrew’s commercial career covered a variety of industries in Australia, Asia and the Americas and was the Victorian Commissioner to the Americas. Andrew holds a Bachelor of Engineering with first class honors from Monash University and an MBA from Georgetown University. He has been a Director since 2015.

Stephanie Bansemer-Brown
Stephanie has over 23 years' experience in the media, sport and entertainment industry. She was Head of Marketing and Publicity for Network Ten in Melbourne for 13 years and since 2013 has consulted in strategic marketing and communications to a number of Australia's big entertainment organisations including the Australian Radio Network, Fremantle Media, and Essential Media. She is currently consulting to the AFL and Bowel Cancer Australia. Stephanie survived stage 3 bowel cancer in 2012 and has been a Director since 2015.

Professor Jane Visvader
BSc (Hons) PhD Adelaide

A scientist specialising in breast cancer research who works for the Walter and Eliza Hall Institute in Melbourne. She is the joint head of the Breast Cancer Laboratory with Professor Geoff Lindeman. She was a joint recipient of the GSK Award for Research Excellence for outstanding contribution to breast cancer research. Jane's most recent award is the 2014 Royal Society of Victoria Research Medal for Scientific Excellence in Biomedical & Health Sciences. She has been a Director since 2015.

All Directors and Board committee members receive no remuneration for their services. They may be reimbursed for reasonable costs and expenses incurred in connection with Board and Board committee activities.